
Blue Owl
North America, New York, United States, New York
Description
Blue Owl is an alternative asset manager that provides investors access to direct lending and GP capital solutions.
Investor Profile
Blue Owl has backed more than 47 startups, with 22 new investments in the last 12 months alone. The firm has led 18 rounds, about 38% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Debt Financing, Post Ipo Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Canada.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 11 rounds in the past year.
Stage Focus
- Debt Financing (23%)
- Post Ipo Equity (21%)
- Series B (11%)
- Series C (9%)
- Post Ipo Debt (9%)
- Series D (6%)
- Private Equity (6%)
- Series A (4%)
- Series Unknown (4%)
- Series F (2%)
Country Focus
- United States (83%)
- United Kingdom (9%)
- Canada (4%)
- Spain (2%)
- Switzerland (2%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Life Science
- Medical
- Financial Services
- Fintech
- Artificial Intelligence (Ai)
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.